Truvian is a healthcare company at the intersection of diagnostics and consumer tech. We are disrupting the blood testing industry by developing an automated, benchtop diagnostic system to provide lab-accurate results in 20 minutes for a comprehensive suite of health tests. Our proprietary approach, for which we are seeking FDA clearance, is intended to fulfill the promise of delivering accessible and affordable blood testing from one small blood sample, in minutes, in a retail setting or private clinic.
Location: United States, California, San Diego
Employees: 51-200
Phone: (858) 251-3646
Total raised: $206.1M
Founded date: 2015
Investors 9
Funding Rounds 3
| Date | Series | Amount | Investors |
| 30.07.2024 | - | $74M | - |
| 25.02.2021 | Series C | $105M | - |
| 27.11.2019 | Series B | $27.1M | - |
Mentions in press and media 24
| Date | Title | Description |
| 30.07.2024 | Truvian Health: Lab-Accurate Results Company Raises $74 Million | Truvian Health announced it is redefining the current global infrastructure through its novel platform, creating a world where central laboratory equivalent blood tests are available anywhere you go. Truvian raised $74 million in funding to... |
| 18.07.2024 | Truvian Health Pioneers Accessible Blood Testing with $74 Million Funding Boost | Truvian Health, a groundbreaking healthcare company based in San Diego, California, has recently secured a substantial $74 million in funding to propel its mission of revolutionizing the accessibility of routine blood testing. This signific... |
| 17.07.2024 | Truvian Health Raises $74M to Bring Blood Testing to Anyone, Anywhere | Wittington Ventures and Great Point Ventures lead round Shoppers Drug Mart, Canada’s largest retail pharmacy chain, joins as a commercial partner New funding to advance Truvian’s clinical trials to secure FDA clearance for its blood testing... |
| 17.07.2024 | Truvian Health Raises $74M in Funding | Truvian Health, a San Diego, CA-based provider of a blood testing platform, raised $74M in funding. The round was led by Wittington Ventures and Great Point Ventures, with participation from existing investors, including DNS Capital, Medica... |
| 25.02.2021 | DLA Piper Advises Truvian Sciences in Oversubscribed $105 Million Series C | DLA Piper represented Truvian Sciences in its recent oversubscribed US$105 million Series C financing. The round was led by TYH Ventures, Glen Tullman of 7wireVentures and Wittington Ventures and was joined by General Catalyst, GreatPoint V... |
| 24.02.2021 | Truvian raises $105 million to commercialize its automated blood-testing platform | San Diego, California-based Truvian, a startup developing blood-testing technology that leans heavily on automation, today announced the close of an over $105 million oversubscribed series C round led by TYH Ventures, 7wireVentures’ Glen Tu... |
| 24.02.2021 | Truvian Sciences Raises More Than $105 Million in Oversubscribed Series C Financing | |
| 24.02.2021 | Truvian raises $105 million to commercialize its automated blood-testing platform | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today! San Diego, California-based Truvian, a startup de... |
| 24.02.2021 | Truvian Sciences Raises More Than $105M in Series C Financing | Truvian Sciences, a San Diego, CA-based closed more than $105m in a Series C financing. The round, which brought total funding to more than $150m to date, was led by TYH Ventures, Glen Tullman of 7wireVentures, and Wittington Ventures. The ... |
| 24.02.2021 | DLA Piper Advises Truvian Sciences in Oversubscribed $105 Million Series C | DLA Piper represented Truvian Sciences in its recent oversubscribed US$105 million Series C financing. The round was led by TYH Ventures, Glen Tullman of 7wireVentures and Wittington Ventures and was joined by General Catalyst, GreatPoint V... |
Show more